138 related articles for article (PubMed ID: 9930673)
1. Molecular modelling and site-directed mutagenesis of the active site of endothelin-converting enzyme.
Sansom CE; Hoang MV; Turner AJ
Protein Eng; 1998 Dec; 11(12):1235-41. PubMed ID: 9930673
[TBL] [Abstract][Full Text] [Related]
2. Mapping the active site of endothelin-converting enzyme-1 through subsite specificity and mutagenesis studies: a comparison with neprilysin.
Johnson GD; Swenson HR; Ramage R; Ahn K
Arch Biochem Biophys; 2002 Feb; 398(2):240-8. PubMed ID: 11831855
[TBL] [Abstract][Full Text] [Related]
3. Mutagenesis of Glu403 to Cys in rabbit neutral endopeptidase-24.11 (neprilysin) creates a disulphide-linked homodimer: analogy with endothelin-converting enzyme.
Hoang MV; Sansom CE; Turner AJ
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):925-9. PubMed ID: 9581575
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling of the active site of endothelin-converting enzyme.
Sansom CE; Hoang VM; Turner AJ
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S75-7. PubMed ID: 8587473
[TBL] [Abstract][Full Text] [Related]
5. A three-dimensional model of endothelin-converting enzyme (ECE) based on the X-ray structure of neutral endopeptidase 24.11 (NEP).
Bur D; Dale GE; Oefner C
Protein Eng; 2001 May; 14(5):337-41. PubMed ID: 11438756
[TBL] [Abstract][Full Text] [Related]
6. Homology modeling and site-directed mutagenesis to identify selective inhibitors of endothelin-converting enzyme-2.
Gagnidze K; Sachchidanand ; Rozenfeld R; Mezei M; Zhou MM; Devi LA
J Med Chem; 2008 Jun; 51(12):3378-87. PubMed ID: 18507370
[TBL] [Abstract][Full Text] [Related]
7. Soluble human endothelin-converting enzyme-1: expression, purification, and demonstration of pronounced pH sensitivity.
Ahn K; Herman SB; Fahnoe DC
Arch Biochem Biophys; 1998 Nov; 359(2):258-68. PubMed ID: 9808768
[TBL] [Abstract][Full Text] [Related]
8. Characterization of CGS 31447, a potent and nonpeptidic endothelin-converting enzyme inhibitor.
Shetty SS; Savage P; DelGrande D; De Lombaert S; Jeng AY
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S68-70. PubMed ID: 9595403
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human endothelin-converting enzyme ECE-1b is located in an intracellular compartment when expressed in polarized Madin-Darby canine kidney cells.
Azarani A; Boileau G; Crine P
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):439-48. PubMed ID: 9657986
[TBL] [Abstract][Full Text] [Related]
10. Structure of human endothelin-converting enzyme I complexed with phosphoramidon.
Schulz H; Dale GE; Karimi-Nejad Y; Oefner C
J Mol Biol; 2009 Jan; 385(1):178-87. PubMed ID: 18992253
[TBL] [Abstract][Full Text] [Related]
11. The peptidase inhibitor CGS-26303 increases endothelin converting enzyme-1 expression in endothelial cells through accumulation of big endothelin-1.
Raoch V; Martinez-Miguel P; Arribas-Gomez I; Rodriguez-Puyol M; Rodriguez-Puyol D; Lopez-Ongil S
Br J Pharmacol; 2007 Oct; 152(3):313-22. PubMed ID: 17643133
[TBL] [Abstract][Full Text] [Related]
12. Development of an internally quenched fluorescent substrate selective for endothelin-converting enzyme-1.
Johnson GD; Ahn K
Anal Biochem; 2000 Nov; 286(1):112-8. PubMed ID: 11038281
[TBL] [Abstract][Full Text] [Related]
13. Secretion of endothelin converting enzyme-1a: the hydrophobic signal anchor domain alone is not sufficient to promote membrane localization.
Brooks SC; Fernandez L; Ergul A
Mol Cell Biochem; 2000 May; 208(1-2):45-51. PubMed ID: 10939627
[TBL] [Abstract][Full Text] [Related]
14. Molecular pharmacology of endothelin converting enzymes.
Turner AJ; Murphy LJ
Biochem Pharmacol; 1996 Jan; 51(2):91-102. PubMed ID: 8615890
[TBL] [Abstract][Full Text] [Related]
15. Rat endothelin-converting enzyme-1 forms a dimer through Cys412 with a similar catalytic mechanism and a distinct substrate binding mechanism compared with neutral endopeptidase-24.11.
Shimada K; Takahashi M; Turner AJ; Tanzawa K
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):863-7. PubMed ID: 8645169
[TBL] [Abstract][Full Text] [Related]
16. Hydrolysis of peptide hormones by endothelin-converting enzyme-1. A comparison with neprilysin.
Johnson GD; Stevenson T; Ahn K
J Biol Chem; 1999 Feb; 274(7):4053-8. PubMed ID: 9933597
[TBL] [Abstract][Full Text] [Related]
17. Construction, expression and characterization of a soluble form of human endothelin-converting-enzyme-1.
Korth P; Egidy G; Parnot C; LeMoullec JM; Corvol P; Pinet F
FEBS Lett; 1997 Nov; 417(3):365-70. PubMed ID: 9409753
[TBL] [Abstract][Full Text] [Related]
18. Anti-peptide antibodies specific to rat endothelin-converting enzyme-1 isoforms reveal isoform localisation and expression.
Brown CD; Barnes K; Turner AJ
FEBS Lett; 1998 Mar; 424(3):183-7. PubMed ID: 9539147
[TBL] [Abstract][Full Text] [Related]
19. cDNA cloning and expression of bovine endothelin converting enzyme.
Ikura T; Sawamura T; Shiraki T; Hosokawa H; Kido T; Hoshikawa H; Shimada K; Tanzawa K; Kobayashi S; Miwa S
Biochem Biophys Res Commun; 1994 Sep; 203(3):1417-22. PubMed ID: 7945289
[TBL] [Abstract][Full Text] [Related]
20. Differential inhibition of wild-type endothelin-converting enzyme-1 and its mutants.
Savage P; De Lombaert S; Shimada K; Tanzawa K; Jeng AY
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S16-8. PubMed ID: 9595388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
